After a median follow-up of 7.9 years, the primary endpoint, 5-year disease-free survival, was 80.3% in the exercise group and 73.9% in the control group (difference, 6.4 percentage points
Treatment is swell-tolerated with little to no downtime
If you need help with the transition phase, have questions or concerns about the medications you are taking, or are interested in alternative mental health treatments in general, our team is here to help
Tirzepatide Starting at: $495 A once-weekly dual GIP and GLP-1 therapy built around your physiology, sourced through a licensed compounding pharmacy, and overseen by our medical director
You have more flexibility than others on daily medications
In comorbid patients, expression of tight junction proteinsincluding occludin, ZO-1, and claudin-1is significantly decreased (Parada Venegas et al., 2019